Regentis Biomaterials (RGNT) Total Current Liabilities (2024 - 2025)
Regentis Biomaterials (RGNT) posted quarterly Total Current Liabilities of $2.9 million for Q4 2025, down 55.7% year-over-year from $6.5 million in Q4 2024, and down 55.7% quarter-over-quarter from $6.5 million in Q4 2024.
Regentis Biomaterials (RGNT) Total Current Liabilities (2024 - 2025) Analysis & Trends
Regentis Biomaterials (RGNT) has reported Total Current Liabilities for 2 consecutive years, with $2.9 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Current Liabilities fell 55.7% year-over-year to $2.9 million; the TTM figure through Dec 2025 stood at $2.9 million (down 55.7% YoY), while the FY2025 annual figure was $2.9 million, down 55.7% from the prior year.
- Total Current Liabilities eased to $2.9 million in Q4 2025 per RGNT's latest filing, from $6.5 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $6.5 million in Q4 2024 and bottomed at $2.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.22 Bn | 129.01 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.46 Bn | 51.59 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.71 Bn | 34.36 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.68 Bn | 32.22 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 29.13 Bn | 26.46 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 25.05 Bn | 24.62 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.37 Bn | 14.97 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.79 Bn | 14.65 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.57 Bn | 11.42 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Regentis Biomaterials | 1.20 Mn | -6.18 Mn | - | 2.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.87 Mn |
| Dec 31, 2024 | 6.49 Mn |